Editorial: Delivery systems in biologics-based therapeutics

Anjaneyulu Dirisala; Junjie Li; Daniel Gonzalez-Carter; Zheng Wang

doi:10.3389/fbioe.2023.1274210

Editorial: Delivery systems in biologics-based therapeutics

Front Bioeng Biotechnol. 2023 Aug 18:11:1274210. doi: 10.3389/fbioe.2023.1274210. eCollection 2023.

Authors

Anjaneyulu Dirisala¹, Junjie Li², Daniel Gonzalez-Carter³, Zheng Wang⁴

Affiliations

¹ Innovation Center of Nanomedicine, Kawasaki Institute of Industrial Promotion, Kawasaki, Japan.
² Institute for Materials Chemistry and Engineering, Kyushu University, Fukuoka, Japan.
³ Molecular Bionics Laboratory, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
⁴ Key Laboratory of Nano BioInterface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.

No abstract available

Keywords: biologics; nanocarriers; nucleic acid medicines; protein drugs; targeting.

Publication types

Editorial

Grants and funding

AD acknowledges the financial support of the Interstellar Initiative Program (22jm0610071h0001) from the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Early-Career Scientist (21K18062 and 18K18393) and Scientific Research (C) (23K11841) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). JL acknowledges the financial support of Grants-in-Aid for Early-Career Scientist (20K20209) and Scientific Research (B) (23H03740). DG-C acknowledges financial support through a “La Caixa Foundation” Junior Leader Research Fellowship (LCF/BQ/PI20/11760003).